Clairity breast: FDA’s first AI-powered 5‑year risk predictor
Breast Cancer Research Foundation - 02-Jun-2025AI reads routine mammograms to deliver personalized 5‑year breast cancer risk scores
Food and Drug Administration (FDA)
Ensuring safety of drugs, medical supplies and food which is used daily.
FDA is an agency within the Department of Health and Human Services.
The FDA's organization consists of the Office of the Commissioner and four directorates overseeing the core functions of the agency: Medical Products and Tobacco, Foods, Global Regulatory Operations and Policy, and Operations.
The FDA is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation.
The FDA is also responsible for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable; and helping the public get the accurate, science-based information they need to use medicines and foods to improve their health.
Visit website: https://www.fda.gov/
Details last updated 21-Oct-2019
Food and Drug Administration (FDA) News
FDA launches full-scale rollout of AI tools after successful pilot
Food and Drug Administration (FDA) - 08-May-2025Generative AI will be deployed across all FDA centres by mid-2025 to streamline scientific reviews
FDA approves first MSC therapy for pediatric graft versus host disease
Food and Drug Administration (FDA) - 18-Dec-2024Ryoncil offers a new treatment option for children with steroid-resistant GVHD
World's first MRI-compatible surgical robot cleared by FDA for breast biopsies
FierceBiotech - 13-Sep-2023Safer, more accurate breast biopsies made possible with IGAR robot
Humacyte's bioengineered tissue outperforms synthetic grafts
FierceBiotech - 12-Sep-2023Human acellular vessel showed better results in vascular trauma repair
Display all news
Food and Drug Administration (FDA) is also referenced in the following:
Deep Medicine
In Deep Medicine, leading physician Eric Topol reveals how artificial intelligence can help
Food and Drug Administration (FDA) Blog Posts
31-Jul-2023
Choosing supplements - why all supplements are not the same
When selecting a supplement, price is not the sole determining factor
16-Jul-2020
Genflow Seeks Investors for Novel SIRT6 DNA Repair Anti-Ageing Therapy
Great to see a startup willing to explicitly state they are treating ageing itself as a disease
03-Feb-2020
Ambrosia Plasma relaunches - announces improvement in key ageing biomarkers
The Club interviews Jesse Karmazin, CEO, to find out more about the trial, the FDA warning, and the relaunch
19-Aug-2019
Does no smoking mean no vaping?
Sometimes news coverage of e-cigarettes can be confusing - what's the best advice?
People at Food and Drug Administration (FDA)
Peter Marks
Peter Marks, M.D., Ph.D. is the director of the Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration
